tm
Seeing Is Believing
tm
Seeing Is Believing
BOLD is currently covered by 2 analysts with an average price target of $7.92. This is a potential upside of $6.46 (442.47%) from yesterday's end of day stock price of $1.46.
Audentes Therapeutics's activity chart (see below) currently has 1 price targets and 4 ratings on display. The stock rating distribution of BOLD is 33.33% HOLD and 66.67% BUY.
Analysts average stock forecasts to be materialized ratio is 85.25% with an average time for these price targets to be met of 187.2 days.
Highest price target for BOLD is $3, Lowest price target is $3, average price target is $3.
Most recent stock forecast was given by MICHAEL CHERNY from LEERINK on 27-May-2025. First documented stock forecast 01-May-2017.
Currently out of the existing stock ratings of BOLD, 1 are a HOLD (33.33%), 2 are a BUY (66.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$3
$1.54 (105.48%)
$25
4 months 29 days ago
(27-May-2025)
0/2 (0%)
$1.8 (150.00%)
Buy
$24
10 months 13 days ago
(13-Dec-2024)
7/8 (87.5%)
$13.99 (139.76%)
90
Buy
$20
$18.86 (1654.39%)
1 years 6 months 4 days ago
(22-Apr-2024)
9/10 (90%)
$9.99 (99.80%)
264
Buy
$48
5 years 10 months 22 days ago
(04-Dec-2019)
4/4 (100%)
$9.47 (24.58%)
224
Hold
$45
5 years 10 months 23 days ago
(03-Dec-2019)
4/4 (100%)
$8.67 (23.86%)
290
What is BOLD (Audentes Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on BOLD (Audentes Therapeutics) with a proven track record?
Which analyst has the most public recommendations on BOLD (Audentes Therapeutics)?
Which analyst is the currently most bullish on BOLD (Audentes Therapeutics)?
Which analyst is the currently most reserved on BOLD (Audentes Therapeutics)?
